Business
    Next Score View the next score

    GlaxoSmithKline to pay Mass. over $35m

    Accord part of $3b US fraud settlement

    The pharmaceutical giant GlaxoSmithKline has agreed to pay more than $35 million to Massachusetts’ Medicaid program as part of a $3 billion settlement with federal and state authorities, the largest health care fraud payment in US history.

    The massive settlement, disclosed Monday by the Department of Justice, includes a guilty plea to three criminal charges by London-based GlaxoSmithKline, which has its US headquarters in Philadelphia.

    Your comment is subject to the rules of our Posting Policy

    This comment may appear on your public profile. Public Profile FAQ